Global Friedreich Ataxia Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Friedreich Ataxia Drug

• 1.1 Definition of Friedreich Ataxia Drug
• 1.2 Friedreich Ataxia Drug Segment by Type
  • 1.2.1 Global Friedreich Ataxia Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 ADVM-063
  • 1.2.3 AGIL-FA
  • 1.2.4 BHV-4157
  • 1.2.5 BVA-202
  • 1.2.6 Others
• 1.3 Friedreich Ataxia Drug Segment by Applications
  • 1.3.1 Global Friedreich Ataxia Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Clinic
  • 1.3.3 Hospital
  • 1.3.4 Others
• 1.4 Global Friedreich Ataxia Drug Overall Market
  • 1.4.1 Global Friedreich Ataxia Drug Revenue (2014-2025)
  • 1.4.2 Global Friedreich Ataxia Drug Production (2014-2025)
  • 1.4.3 North America Friedreich Ataxia Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Friedreich Ataxia Drug Status and Prospect (2014-2025)
  • 1.4.5 China Friedreich Ataxia Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Friedreich Ataxia Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Friedreich Ataxia Drug Status and Prospect (2014-2025)
  • 1.4.8 India Friedreich Ataxia Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Friedreich Ataxia Drug
• 2.3 Manufacturing Process Analysis of Friedreich Ataxia Drug
• 2.4 Industry Chain Structure of Friedreich Ataxia Drug

3 Development and Manufacturing Plants Analysis of Friedreich Ataxia Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Friedreich Ataxia Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Friedreich Ataxia Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Friedreich Ataxia Drug Production and Capacity Analysis
• 4.2 Friedreich Ataxia Drug Revenue Analysis
• 4.3 Friedreich Ataxia Drug Price Analysis
• 4.4 Market Concentration Degree

5 Friedreich Ataxia Drug Regional Market Analysis

• 5.1 Friedreich Ataxia Drug Production by Regions
  • 5.1.1 Global Friedreich Ataxia Drug Production by Regions
  • 5.1.2 Global Friedreich Ataxia Drug Revenue by Regions
• 5.2 Friedreich Ataxia Drug Consumption by Regions
• 5.3 North America Friedreich Ataxia Drug Market Analysis
  • 5.3.1 North America Friedreich Ataxia Drug Production
  • 5.3.2 North America Friedreich Ataxia Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Friedreich Ataxia Drug Import and Export
• 5.4 Europe Friedreich Ataxia Drug Market Analysis
  • 5.4.1 Europe Friedreich Ataxia Drug Production
  • 5.4.2 Europe Friedreich Ataxia Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Friedreich Ataxia Drug Import and Export
• 5.5 China Friedreich Ataxia Drug Market Analysis
  • 5.5.1 China Friedreich Ataxia Drug Production
  • 5.5.2 China Friedreich Ataxia Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Friedreich Ataxia Drug Import and Export
• 5.6 Japan Friedreich Ataxia Drug Market Analysis
  • 5.6.1 Japan Friedreich Ataxia Drug Production
  • 5.6.2 Japan Friedreich Ataxia Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Friedreich Ataxia Drug Import and Export
• 5.7 Southeast Asia Friedreich Ataxia Drug Market Analysis
  • 5.7.1 Southeast Asia Friedreich Ataxia Drug Production
  • 5.7.2 Southeast Asia Friedreich Ataxia Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Friedreich Ataxia Drug Import and Export
• 5.8 India Friedreich Ataxia Drug Market Analysis
  • 5.8.1 India Friedreich Ataxia Drug Production
  • 5.8.2 India Friedreich Ataxia Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Friedreich Ataxia Drug Import and Export

6 Friedreich Ataxia Drug Segment Market Analysis (by Type)

• 6.1 Global Friedreich Ataxia Drug Production by Type
• 6.2 Global Friedreich Ataxia Drug Revenue by Type
• 6.3 Friedreich Ataxia Drug Price by Type

7 Friedreich Ataxia Drug Segment Market Analysis (by Application)

• 7.1 Global Friedreich Ataxia Drug Consumption by Application
• 7.2 Global Friedreich Ataxia Drug Consumption Market Share by Application (2014-2019)

8 Friedreich Ataxia Drug Major Manufacturers Analysis

• 8.1 Adverum Biotechnologies Inc
  • 8.1.1 Adverum Biotechnologies Inc Friedreich Ataxia Drug Production Sites and Area Served
  • 8.1.2 Adverum Biotechnologies Inc Product Introduction, Application and Specification
  • 8.1.3 Adverum Biotechnologies Inc Friedreich Ataxia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 BioMarin Pharmaceutical Inc.
  • 8.2.1 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Production Sites and Area Served
  • 8.2.2 BioMarin Pharmaceutical Inc. Product Introduction, Application and Specification
  • 8.2.3 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Biovista Inc.
  • 8.3.1 Biovista Inc. Friedreich Ataxia Drug Production Sites and Area Served
  • 8.3.2 Biovista Inc. Product Introduction, Application and Specification
  • 8.3.3 Biovista Inc. Friedreich Ataxia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Cardero Therapeutics Inc
  • 8.4.1 Cardero Therapeutics Inc Friedreich Ataxia Drug Production Sites and Area Served
  • 8.4.2 Cardero Therapeutics Inc Product Introduction, Application and Specification
  • 8.4.3 Cardero Therapeutics Inc Friedreich Ataxia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Catabasis Pharmaceuticals, Inc.
  • 8.5.1 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Production Sites and Area Served
  • 8.5.2 Catabasis Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.5.3 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Forward Pharma A/S
  • 8.6.1 Forward Pharma A/S Friedreich Ataxia Drug Production Sites and Area Served
  • 8.6.2 Forward Pharma A/S Product Introduction, Application and Specification
  • 8.6.3 Forward Pharma A/S Friedreich Ataxia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Ixchel Pharma LLC
  • 8.7.1 Ixchel Pharma LLC Friedreich Ataxia Drug Production Sites and Area Served
  • 8.7.2 Ixchel Pharma LLC Product Introduction, Application and Specification
  • 8.7.3 Ixchel Pharma LLC Friedreich Ataxia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Pfizer Inc
  • 8.8.1 Pfizer Inc Friedreich Ataxia Drug Production Sites and Area Served
  • 8.8.2 Pfizer Inc Product Introduction, Application and Specification
  • 8.8.3 Pfizer Inc Friedreich Ataxia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 ProQR Therapeutics NV
  • 8.9.1 ProQR Therapeutics NV Friedreich Ataxia Drug Production Sites and Area Served
  • 8.9.2 ProQR Therapeutics NV Product Introduction, Application and Specification
  • 8.9.3 ProQR Therapeutics NV Friedreich Ataxia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 RaNA Therapeutics Inc
  • 8.10.1 RaNA Therapeutics Inc Friedreich Ataxia Drug Production Sites and Area Served
  • 8.10.2 RaNA Therapeutics Inc Product Introduction, Application and Specification
  • 8.10.3 RaNA Therapeutics Inc Friedreich Ataxia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Reata Pharmaceuticals Inc
• 8.12 Retrotope Inc
• 8.13 Shire Plc
• 8.14 STATegics Inc
• 8.15 Voyager Therapeutics Inc

9 Development Trend of Analysis of Friedreich Ataxia Drug Market

• 9.1 Global Friedreich Ataxia Drug Market Trend Analysis
  • 9.1.1 Global Friedreich Ataxia Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Friedreich Ataxia Drug Regional Market Trend
  • 9.2.1 North America Friedreich Ataxia Drug Forecast 2019-2025
  • 9.2.2 Europe Friedreich Ataxia Drug Forecast 2019-2025
  • 9.2.3 China Friedreich Ataxia Drug Forecast 2019-2025
  • 9.2.4 Japan Friedreich Ataxia Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Friedreich Ataxia Drug Forecast 2019-2025
  • 9.2.6 India Friedreich Ataxia Drug Forecast 2019-2025
• 9.3 Friedreich Ataxia Drug Market Trend (Product Type)
• 9.4 Friedreich Ataxia Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Friedreich Ataxia Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List